Midgard Science

Labs / Assays & in vitro testing

P

Priavoid

Düsseldorf, Germany · priavoid.com

On your own

Free. Their own form.

Contact Priavoid directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Priavoid develops orally available all-D-peptide therapeutics that target neurotoxic protein aggregation in neurodegenerative disorders. The company is based in Düsseldorf, Germany, and focuses on Alzheimer’s disease, synucleinopathies such as Parkinson’s disease and multiple system atrophy, tau-related disease, and amyotrophic lateral sclerosis.

They take quote requests by email.

What they offer

  • Drug discovery platform for all-D-peptide therapeutics

    Identifies and designs tailored all-D-peptide compounds against toxic oligomers using mirror-image-phage-display technology and rational design.

  • Peptide optimization

    Optimizes candidate peptides for efficacy, stability, and penetration of the blood-brain barrier and cell membranes.

  • Preclinical development

    Advances platform-derived programs through preclinical development for neurodegenerative indications.

  • Clinical development

    Advances lead program PRI-002 in Phase 2 clinical development for Alzheimer’s disease.

What they work on

Modalities
Peptide, Oligonucleotide
Assays and studies
mirror-image-phage-display technology, rational design, protein aggregation targeting, oligomer disassembly
Therapeutic areas
neurodegenerative disorders, Alzheimer’s disease, Parkinson’s disease, multiple system atrophy, amyotrophic lateral sclerosis
Sites
Düsseldorf, Germany
Address
Merowingerplatz 1 A 40225 Düsseldorf
Founded
2004

Similar labs. Devsynthesis, MedChem Partners, Novalix, Sparx BIO

Found in a contract services directory. Listing built from priavoid.com. Work here? Claim this listing.

Priavoid · Midgard Science